Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
2014 · Journal of Gastroenterology · 39 citations
https://doi.org/10.1007/s00535-014-0936-0
T
Tadaaki Arizumi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
185
Papers
2.9K
Citations
29
h-index
53
i10-index
Tadaaki Arizumi is an academic researcher from Kindai University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Diverse Scientific and Economic Studies. The author has an h-index of 29, co-authored 158 publications.
Papers by this author
worksSupplementary Material for: MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma
2016 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4476227
Supplementary Material for: Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
2014 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5127091
Supplementary Material for: Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma
2014 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5127094
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat